Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ernest Fraenkel is active.

Publication


Featured researches published by Ernest Fraenkel.


Nature | 2004

Transcriptional regulatory code of a eukaryotic genome

Christopher T. Harbison; D. Benjamin Gordon; Tong Ihn Lee; Nicola J. Rinaldi; Kenzie D. MacIsaac; Timothy Danford; Nancy M. Hannett; Jean-Bosco Tagne; David B. Reynolds; Jane Yoo; Ezra G. Jennings; Julia Zeitlinger; Dmitry K. Pokholok; Manolis Kellis; P. Alex Rolfe; Ken T. Takusagawa; Eric S. Lander; David K. Gifford; Ernest Fraenkel; Richard A. Young

DNA-binding transcriptional regulators interpret the genomes regulatory code by binding to specific sequences to induce or repress gene expression. Comparative genomics has recently been used to identify potential cis-regulatory sequences within the yeast genome on the basis of phylogenetic conservation, but this information alone does not reveal if or when transcriptional regulators occupy these binding sites. We have constructed an initial map of yeasts transcriptional regulatory code by identifying the sequence elements that are bound by regulators under various conditions and that are conserved among Saccharomyces species. The organization of regulatory elements in promoters and the environment-dependent use of these elements by regulators are discussed. We find that environment-specific use of regulatory elements predicts mechanistic models for the function of a large population of yeasts transcriptional regulators.


Nature | 2007

Foxp3 occupancy and regulation of key target genes during T-cell stimulation.

Alexander Marson; Karsten Kretschmer; Garrett M. Frampton; Elizabeth S. Jacobsen; Julia K. Polansky; Kenzie D. MacIsaac; Stuart S. Levine; Ernest Fraenkel; Harald von Boehmer; Richard A. Young

Foxp3+CD4+CD25+ regulatory T (Treg) cells are essential for the prevention of autoimmunity. Treg cells have an attenuated cytokine response to T-cell receptor stimulation, and can suppress the proliferation and effector function of neighbouring T cells. The forkhead transcription factor Foxp3 (forkhead box P3) is selectively expressed in Treg cells, is required for Treg development and function, and is sufficient to induce a Treg phenotype in conventional CD4+CD25- T cells. Mutations in Foxp3 cause severe, multi-organ autoimmunity in both human and mouse. FOXP3 can cooperate in a DNA-binding complex with NFAT (nuclear factor of activated T cells) to regulate the transcription of several known target genes. However, the global set of genes regulated directly by Foxp3 is not known and consequently, how this transcription factor controls the gene expression programme for Treg function is not understood. Here we identify Foxp3 target genes and report that many of these are key modulators of T-cell activation and function. Remarkably, the predominant, although not exclusive, effect of Foxp3 occupancy is to suppress the activation of target genes on T-cell stimulation. Foxp3 suppression of its targets appears to be crucial for the normal function of Treg cells, because overactive variants of some target genes are known to be associated with autoimmune disease.


Nature Genetics | 2007

Tissue-specific transcriptional regulation has diverged significantly between human and mouse

Duncan T. Odom; Robin D. Dowell; Elizabeth S. Jacobsen; William Gordon; Timothy Danford; Kenzie D. MacIsaac; P. Alexander Rolfe; Caitlin M. Conboy; David K. Gifford; Ernest Fraenkel

We demonstrate that the binding sites for highly conserved transcription factors vary extensively between human and mouse. We mapped the binding of four tissue-specific transcription factors (FOXA2, HNF1A, HNF4A and HNF6) to 4,000 orthologous gene pairs in hepatocytes purified from human and mouse livers. Despite the conserved function of these factors, from 41% to 89% of their binding events seem to be species specific. When the same protein binds the promoters of orthologous genes, approximately two-thirds of the binding sites do not align.


Nature Genetics | 2009

Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity

Esti Yeger-Lotem; Laura Riva; Linhui Julie Su; Aaron D. Gitler; Anil G. Cashikar; Oliver D. King; Pavan K. Auluck; Melissa L. Geddie; Julie Suzanne Valastyan; David R. Karger; Susan Lindquist; Ernest Fraenkel

Cells respond to stimuli by changes in various processes, including signaling pathways and gene expression. Efforts to identify components of these responses increasingly depend on mRNA profiling and genetic library screens. By comparing the results of these two assays across various stimuli, we found that genetic screens tend to identify response regulators, whereas mRNA profiling frequently detects metabolic responses. We developed an integrative approach that bridges the gap between these data using known molecular interactions, thus highlighting major response pathways. We used this approach to reveal cellular pathways responding to the toxicity of alpha-synuclein, a protein implicated in several neurodegenerative disorders including Parkinsons disease. For this we screened an established yeast model to identify genes that when overexpressed alter alpha-synuclein toxicity. Bridging these data and data from mRNA profiling provided functional explanations for many of these genes and identified previously unknown relations between alpha-synuclein toxicity and basic cellular pathways.


Molecular Cell | 2009

Insights into GATA-1-Mediated Gene Activation versus Repression via Genome-wide Chromatin Occupancy Analysis

Ming Yu; Laura Riva; Huafeng Xie; Yocheved Schindler; Tyler B. Moran; Yong Cheng; Duonan Yu; Ross C. Hardison; Mitchell J. Weiss; Stuart H. Orkin; Bradley E. Bernstein; Ernest Fraenkel; Alan Cantor

The transcription factor GATA-1 is required for terminal erythroid maturation and functions as an activator or repressor depending on gene context. Yet its in vivo site selectivity and ability to distinguish between activated versus repressed genes remain incompletely understood. In this study, we performed GATA-1 ChIP-seq in erythroid cells and compared it to GATA-1-induced gene expression changes. Bound and differentially expressed genes contain a greater number of GATA-binding motifs, a higher frequency of palindromic GATA sites, and closer occupancy to the transcriptional start site versus nondifferentially expressed genes. Moreover, we show that the transcription factor Zbtb7a occupies GATA-1-bound regions of some direct GATA-1 target genes, that the presence of SCL/TAL1 helps distinguish transcriptional activation versus repression, and that polycomb repressive complex 2 (PRC2) is involved in epigenetic silencing of a subset of GATA-1-repressed genes. These data provide insights into GATA-1-mediated gene regulation in vivo.


Molecular Systems Biology | 2006

Core transcriptional regulatory circuitry in human hepatocytes

Duncan T. Odom; Robin D. Dowell; Elizabeth S. Jacobsen; Lena Nekludova; P. Alexander Rolfe; Timothy Danford; David K. Gifford; Ernest Fraenkel; Graeme I. Bell; Richard A. Young

We mapped the transcriptional regulatory circuitry for six master regulators in human hepatocytes using chromatin immunoprecipitation and high‐resolution promoter microarrays. The results show that these regulators form a highly interconnected core circuitry, and reveal the local regulatory network motifs created by regulator–gene interactions. Autoregulation was a prominent theme among these regulators. We found that hepatocyte master regulators tend to bind promoter regions combinatorially and that the number of transcription factors bound to a promoter corresponds with observed gene expression. Our studies reveal portions of the core circuitry of human hepatocytes.


PLOS Computational Biology | 2006

Practical Strategies for Discovering Regulatory DNA Sequence Motifs

Kenzie D. MacIsaac; Ernest Fraenkel

Many functionally important regions of the genome can be recognized by searching for sequence patterns, or “motifs.” Aside from the genes themselves, examples include CpG islands, often present in promoter regions, and splice sites that denote intron/exon boundaries. Other motifs of great interest correspond to sites bound by regulatory proteins. Differential expression of genes in response to environmental and developmental cues depends on the action of these proteins, which are also known as transcription factors. Identifying the regulatory motifs bound by transcription factors can provide crucial insight into the mechanisms of transcriptional regulation. However, the search for these sites is challenging because a single regulatory protein will often recognize a variety of similar sequences. In this tutorial, we review computational techniques, termed “motif discovery,” to learn representations of regulatory motifs from sequence data. In Figure 1, we present an overview of the basic workflow in a motif discovery analysis and some practical strategies for successfully mining sequence data for biologically important regulatory motifs. In the remainder of this tutorial, we discuss the main challenges associated with motif discovery in detail, and we review recent developments for addressing these challenges. Figure 1 Motif Discovery Workflow


Science Signaling | 2009

Integrating Proteomic, Transcriptional, and Interactome Data Reveals Hidden Components of Signaling and Regulatory Networks

Shao-shan Carol Huang; Ernest Fraenkel

Analysis of multiple “omic” data sets with a prize-collecting Steiner tree algorithm reveals components of signaling networks that are not obvious by analyzing the data individually. Finding the Missing Links Constructing signaling networks that are meaningful and useful from high-throughput data sets is a major challenge in systems biology. Huang and Fraenkel present a computational approach based on the prize-collecting Steiner tree (PCST) problem that integrates diverse data sets, and by allowing indirect connections it yields relatively small, but functionally relevant, networks. For the yeast pheromone response pathway, they relate transcription expression data to data from genetic screens and data from phosphoproteomic analysis through a PCST analysis to reveal previously unidentified connections and components not readily apparent from either data set. Cellular signaling and regulatory networks underlie fundamental biological processes such as growth, differentiation, and response to the environment. Although there are now various high-throughput methods for studying these processes, knowledge of them remains fragmentary. Typically, the majority of hits identified by transcriptional, proteomic, and genetic assays lie outside of the expected pathways. These unexpected components of the cellular response are often the most interesting, because they can provide new insights into biological processes and potentially reveal new therapeutic approaches. However, they are also the most difficult to interpret. We present a technique, based on the Steiner tree problem, that uses previously reported protein-protein and protein-DNA interactions to determine how these hits are organized into functionally coherent pathways, revealing many components of the cellular response that are not readily apparent in the original data. Applied simultaneously to phosphoproteomic and transcriptional data for the yeast pheromone response, it identifies changes in diverse cellular processes that extend far beyond the expected pathways.


Disease Models & Mechanisms | 2010

Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models.

Linhui Julie Su; Pavan K. Auluck; Tiago F. Outeiro; Esti Yeger-Lotem; Joshua A. Kritzer; Daniel F. Tardiff; Katherine E. Strathearn; Fang Liu; Songsong Cao; Shusei Hamamichi; Kathryn J. Hill; Kim A. Caldwell; George W. Bell; Ernest Fraenkel; Antony A. Cooper; Guy A. Caldwell; J. Michael McCaffery; Jean-Christophe Rochet; Susan Lindquist

SUMMARY α-Synuclein (α-syn) is a small lipid-binding protein involved in vesicle trafficking whose function is poorly characterized. It is of great interest to human biology and medicine because α-syn dysfunction is associated with several neurodegenerative disorders, including Parkinson’s disease (PD). We previously created a yeast model of α-syn pathobiology, which established vesicle trafficking as a process that is particularly sensitive to α-syn expression. We also uncovered a core group of proteins with diverse activities related to α-syn toxicity that is conserved from yeast to mammalian neurons. Here, we report that a yeast strain expressing a somewhat higher level of α-syn also exhibits strong defects in mitochondrial function. Unlike our previous strain, genetic suppression of endoplasmic reticulum (ER)-to-Golgi trafficking alone does not suppress α-syn toxicity in this strain. In an effort to identify individual compounds that could simultaneously rescue these apparently disparate pathological effects of α-syn, we screened a library of 115,000 compounds. We identified a class of small molecules that reduced α-syn toxicity at micromolar concentrations in this higher toxicity strain. These compounds reduced the formation of α-syn foci, re-established ER-to-Golgi trafficking and ameliorated α-syn-mediated damage to mitochondria. They also corrected the toxicity of α-syn in nematode neurons and in primary rat neuronal midbrain cultures. Remarkably, the compounds also protected neurons against rotenone-induced toxicity, which has been used to model the mitochondrial defects associated with PD in humans. That single compounds are capable of rescuing the diverse toxicities of α-syn in yeast and neurons suggests that they are acting on deeply rooted biological processes that connect these toxicities and have been conserved for a billion years of eukaryotic evolution. Thus, it seems possible to develop novel therapeutic strategies to simultaneously target the multiple pathological features of PD.


Molecular and Cellular Biology | 2000

Assembly of a Functional Beta Interferon Enhanceosome Is Dependent on ATF-2–c-jun Heterodimer Orientation

James V. Falvo; Bhavin S. Parekh; Charles H. Lin; Ernest Fraenkel; Tom Maniatis

ABSTRACT Heterodimeric transcription factors, including the basic region-leucine zipper (bZIP) protein ATF-2–c-jun, are well-characterized components of an enhanceosome that mediates virus induction of the human beta interferon (IFN-β) gene. Here we report that within the IFN-β enhanceosome the ATF-2–c-jun heterodimer binds in a specific orientation, which is required for assembly of a complex between ATF-2–c-jun and interferon regulatory factor 3 (IRF-3). We demonstrate that correct orientation of the ATF-2–c-jun binding site is required for virus induction of the IFN-β gene and for IRF-3-dependent activation of a composite ATF-2– c-jun–IRF site in the IFN-β promoter. We also show that in vitro the DNA-bound ATF-2–c-jun heterodimer adopts a fixed orientation upon the binding of IRF-3 at an adjacent site in the IFN-β enhancer and that the DNA-binding domain of IRF-3 is sufficient to mediate this effect. In addition, we show that the DNA-binding domain of ATF-2 is necessary and sufficient for selective protein-protein interactions with IRF-3. Strikingly, in vivo chromatin immunoprecipitation experiments with IFN-β reporter constructs reveal that recruitment of IRF-3 to the IFN-β promoter upon virus infection is dependent on the orientation of the ATF-2–c-jun heterodimer binding site. These observations demonstrate functional and physical cooperativity between the bZIP and IRF transcription factor families and illustrate the critical role of heterodimeric transcription factors in formation of the IFN-β enhanceosome.

Collaboration


Dive into the Ernest Fraenkel's collaboration.

Top Co-Authors

Avatar

Kenzie D. MacIsaac

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Pamela Milani

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

David K. Gifford

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Richard A. Young

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Shao-shan Carol Huang

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Simona Dalin

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bryan J. Matthews

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

D. Benjamin Gordon

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Douglas A. Lauffenburger

Massachusetts Institute of Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge